IDiyas

For the Inventor, By the Inventor

Kawachinagano, Japan

Matazaemon Uchida

USPTO Granted Patents = 9

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 67(Granted Patents)


Company Filing History:

goldMedal9 out of 181 
 
Nihon Nohyaku Co., Ltd.
 patents

Years Active: 1987-1992

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5098928 - Ketendithioacetal derivatives and pharmaceutical compositions containing (1992-03-24),
2. 5045562 - 1,3,5-trithiane derivatives and pharmaceutical compositions thereof (1991-09-03),
3. 5041440 - Dithiolane derivatives (1991-08-20),
4. 4910217 - Curing agent for fat necrosis and method for curing said disease (1990-03-20),
5. 4863925 - Cyclohexanedione derivative for hepatic disorders and a process for (1989-09-05),
6. 4835153 - Malonic acid derivatives (1989-05-30),
7. 4816475 - 1,3,5-trithian derivatives and pharmaceutical compositions (1989-03-28),
8. 4738976 - Antimycotic agent and fungicidal agent (1988-04-19),
9. 4636519 - Ketene S,S-acetal derivative, a process for manufacturing thereof and a (1987-01-13),

Title: Matazaemon Uchida: Innovator in Pharmaceutical Compositions

Introduction

Matazaemon Uchida is a prominent inventor based in Kawachinagano, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 9 patents. His work focuses on developing innovative compounds that have therapeutic applications, particularly in the treatment of arteriosclerosis and hyperlipidemia.

Latest Patents

Uchida's latest patents include the development of ketendithioacetal derivatives and pharmaceutical compositions containing these compounds. The ketendithioacetal derivatives of formula (I) exhibit potent hypolipidemic and anti-arteriosclerotic effects, making them useful for the prophylaxis and treatment of arteriosclerosis or hyperlipidemia. Another notable patent involves 1,3,5-trithiane derivatives and their pharmaceutical compositions. These derivatives, represented by the formula (I), are disclosed as effective anti-arteriosclerotic or anti-hyperlipemic agents.

Career Highlights

Matazaemon Uchida is associated with Nihon Nohyaku Co., Ltd., where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the pharmaceutical industry, contributing to the creation of effective treatments for cardiovascular conditions.

Collaborations

Uchida has collaborated with notable coworkers, including Kunikazu Hiraga and Keisuke Nakayama. Their combined expertise has further enhanced the research and development of new pharmaceutical compositions.

Conclusion

Matazaemon Uchida's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to influence the development of effective treatments for serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…